We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Guidewire's (GWRE) first-quarter fiscal 2022 results benefit from strength in subscription revenues. Weakness in license and service revenues is a headwind.
Okta's (OKTA) third-quarter fiscal 2022 results benefit from customer additions and growing international momentum driven by increasing adoption of Identity solutions.
Zuora's (ZUO) third-quarter fiscal 2022 results reflect robust performance based on the strong uptake of its business platform and the resilience in the cloud subscription-based business model.
OKTA's third-quarter fiscal 2022 results are expected to reflect continued adoption of Identity solutions. However, growing investments are likely to keep margins under pressure.
Anaplan's (PLAN) third-quarter fiscal 2022 results reflect an expanding need for enterprise-wide planning, driven by higher demand for its digital transformation services.
saas: Archive
Asana (ASAN) Incurs Loss in Q3, User Expansion Aids Top Line
by Zacks Equity Research
Asana's (ASAN) third-quarter fiscal 2022 results benefit from an expanding user base and strong retention rate.
AMDNegative Net Change NVMINegative Net Change PINSNegative Net Change ASANNegative Net Change
saas tech-stocks
Guidewire (GWRE) Incurs Loss in Q1, Revenues Top Estimates
by Zacks Equity Research
Guidewire's (GWRE) first-quarter fiscal 2022 results benefit from strength in subscription revenues. Weakness in license and service revenues is a headwind.
AMDNegative Net Change GWRENegative Net Change NVMINegative Net Change PINSNegative Net Change
saas tech-stocks
DOMO Q3 Earnings Surpass Estimates, Revenues Improve Y/Y
by Zacks Equity Research
Domo Inc.'s (DOMO) third-quarter fiscal 2022 results reflect growth in subscription revenues amid higher expenses.
AMDNegative Net Change NVMINegative Net Change DOMONegative Net Change PINSNegative Net Change
saas tech-stocks
Should You Buy HP (HPQ) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
HPQNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
OKTA Incurs Loss in Q3, Subscription Revenues Increase Y/Y
by Aniruddha Ganguly
Okta's (OKTA) third-quarter fiscal 2022 results benefit from customer additions and growing international momentum driven by increasing adoption of Identity solutions.
AMDNegative Net Change NVMINegative Net Change OKTANegative Net Change PINSNegative Net Change
saas tech-stocks
Splunk (SPLK) Tops Estimates in Q3 Earnings, Revenues Up Y/Y
by Zacks Equity Research
Splunk's (SPLK) third-quarter fiscal 2022 results reflect growth in cloud revenues and customer base expansion amid higher expenses.
AMDNegative Net Change ACNNegative Net Change SPLKNegative Net Change NVMINegative Net Change
saas tech-stocks
Snowflake (SNOW) Tops Estimates in Q3 Earnings, Revenues Up Y/Y
by Zacks Equity Research
Snowflake's (SNOW) third-quarter fiscal 2022 results reflect growth in product revenues and customer-base expansion amid higher expenses.
AMDNegative Net Change NVMINegative Net Change SNOWNegative Net Change PINSNegative Net Change
saas tech-stocks
Zuora (ZUO) Earnings Top Estimates in Q3, Revenues Up Y/Y
by Zacks Equity Research
Zuora's (ZUO) third-quarter fiscal 2022 results reflect robust performance based on the strong uptake of its business platform and the resilience in the cloud subscription-based business model.
AMDNegative Net Change NVMINegative Net Change ZUONegative Net Change PINSNegative Net Change
saas tech-stocks
Coupa (COUP) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Coupa Software's (COUP) fiscal third-quarter results are likely to reflect strong demand for Coupa BSM and market traction of Coupa Pay offerings.
SPLKNegative Net Change COUPNegative Net Change SNOWNegative Net Change CRWDNegative Net Change
earnings saas tech-stocks
Asana (ASAN) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Asana's (ASAN) fiscal third-quarter performance is expected to have benefited from expansion of its enterprise customer base.
COUPNegative Net Change SNOWNegative Net Change CRWDNegative Net Change ASANNegative Net Change
earnings saas tech-stocks
C3.ai (AI) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
C3.ai's (AI) Q2 results are expected to reflect increased demand for the company's expanding AI product suite.
MSFTNegative Net Change BLLNegative Net Change AINegative Net Change SNOWNegative Net Change
artificial-intelligence earnings saas tech-stocks
Fluor (FLR) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
FLRNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
OKTA Gears Up to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
OKTA's third-quarter fiscal 2022 results are expected to reflect continued adoption of Identity solutions. However, growing investments are likely to keep margins under pressure.
COUPNegative Net Change SNOWNegative Net Change OKTANegative Net Change CRWDNegative Net Change
earnings saas tech-stocks
Snowflake (SNOW) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Snowflake's (SNOW) third-quarter fiscal 2022 results are likely to benefit from strong demand for the Data Cloud platform and expanded clientele.
CNegative Net Change COUPNegative Net Change SNOWNegative Net Change CRWDNegative Net Change
cloud-computing earnings saas tech-stocks
Sierra Wireless (SWIR)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
SWIRNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Pulse Biosciences, Inc (PLSE)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PLSENegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Five Below (FIVE)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
FIVENegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
First Financial Corp. (THFF) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
THFFNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, Accuray (ARAY)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
ARAYNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Anaplan (PLAN) Q3 Loss Narrower Than Expected, Revenues Up Y/Y
by Zacks Equity Research
Anaplan's (PLAN) third-quarter fiscal 2022 results reflect an expanding need for enterprise-wide planning, driven by higher demand for its digital transformation services.
CRMNegative Net Change JBLNegative Net Change HPEPositive Net Change PLANNegative Net Change
earnings internet-content saas tech-stocks
After Golden Cross, Under Armour (UAA)'s Technical Outlook is Bright
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
UAANegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
BioMarin Pharmaceutical (BMRN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
BMRNNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
MarineMax (HZO)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
HZONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Ametek (AME)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
AMEPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Zoom's (ZM) Q3 Earnings Top Estimates, Revenues Jump Y/Y
by Zacks Equity Research
Zoom's (ZM) third-quarter fiscal 2022 results reflect steady user growth, driven by remote-working and online-learning wave.
CRMNegative Net Change JBLNegative Net Change HPEPositive Net Change ZMNegative Net Change
internet-content saas tech-stocks